Castellum, Viracta Therapeutics And 3 Stocks To Watch Heading Into Friday (CORRECTED)

Editor’s note: This story has been corrected to state that Castellum Inc — not Constellium SE — announced the pricing of a public stock offering.

With U.S. stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:

• Viracta Therapeutics, Inc. VIRX said its board has initiated a process to explore a broad range of strategic alternatives. The company announced plans to close its ongoing pivotal Phase 2 clinical trial of Nana-val in Relapsed/Refractory EBV + Lymphomas. Viracta Therapeutics shares dipped 13.9% to $0.2040 in the after-hours trading session.
• Evaxion Biotech A/S EVAX applied for a patent for vaccines targeting Neisseria gonorrhoeae. Evaxion Biotech shares jumped 104.5% to $1.73 in after-hours trading.
• Castellum Inc CTM announced the pricing of a previously announced stock offering of 4,355,000 shares at 85 cents per share for gross proceeds of approximately $3.7 million.

Check out our premarket coverage here.

• The Arena Group Holdings, Inc. AREN disclosed that its compliance plan was accepted by the NYSE American. Arena Group shares jumped 17.6% to $1.67 in the after-hours trading session.
• Grid Dynamics Holdings, Inc. GDYN will replace Revelyst Inc. GEAR in the S&P SmallCap 600 effective before the opening bell on Thursday, Jan. 2. Grid Dynamics shares jumped 9.7% to $23.11 in after-hours trading.

Check This Out:

Photo courtesy: Wikimedia